Published in Women's Health Weekly, October 24th, 2002
Each warrant holder who exercised received an equal number of replacement warrants. The proceeds will be used in part to accelerate the company's clinical testing of its products for the treatment of female stress urinary incontinence and for the correction of dermal contour deficiencies.
"We continue to make progress in developing PPTI's tissue augmentation products and tissue adhesive technology. Through our partner, Femcare, Ltd., European clinical trials of our female stress...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly